Trial Profile

Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 04 Apr 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nitazoxanide (Primary) ; Clarithromycin; Doxycycline; Levofloxacin; Metronidazole; Omeprazole
Indications Helicobacter pylori infections
Focus Therapeutic Use

Most Recent Events

04 Apr 2019 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified April 2017).
06 Dec 2017 Status changed to active, no longer recruiting.
01 Nov 2017 Results assessing the efficacy and safety of a unique triple Nitazoxanide containing regimen presented at the 25th United European Gastroenterology Week

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com